Found 513 results
STAT’s Health Tech newsletter previews an EPIC investigation and a Teladoc surprise, alongside its planned HLTH event in...
Starting July 2027, PBMs must disclose rebates, spread pricing and other compensation to employer clients under a rule p...
A Texas patient expected a routine UTI visit to cost $211. A later $1,756 charge from a hybrid ER-urgent care clinic spa...
A letter Jane Butt wrote in 1834 described measles spreading among children in Broughton, with 36 reported cases and lun...
AstraZeneca plans $1.5 billion in yearly savings for R&D, while Sun Pharma must stop eye-care production at an Assam pla...
STAT’s The Readout LOUD discusses reactions to Merck and Moderna’s cancer vaccine data and other findings presented at E...
Epic generates more than $6.5 billion annually and holds data on 8 in 10 Americans. Health tech firms say its access pol...
Epic’s records cover about 8 in 10 Americans. STAT is seeking firsthand accounts of how its business practices affect ho...
A Pennsylvania pediatrician sees sharply divided views on MMR vaccination and says health and child care providers need...
At 80 weeks, participants on the highest retatrutide dose saw greater A1c reductions and weight loss than those taking O...
Eli Lilly says retatrutide lowered blood sugar and weight more than Ozempic in a large diabetes study, putting its inves...
Missouri’s attorney general warns Lilly over hospital claims data for 340B discounts, while new FDA draft guidance outli...
STAT’s newsletter points readers to a story on Epic and health care AI, alongside notes from an apple tasting.
HHS will temporarily shield certain pharmacies and physicians from enforcement as they compound six peptides while the F...
Remibrutinib reduced relapse rates versus Aubagio in two Phase 3 studies, while its safety profile may help it compete w...
An analysis found high clinical benefit in 31% of cancer treatment indications approved in Europe from January 2022 thro...
A patient died after complications in Bristol Myers Squibb’s Phase 1 autoimmune CAR-T trial; prior treatment complicates...
The ADA cited a written threat before ejecting five members, while acknowledging its conduct code didn’t clearly bar dis...
Highly anticipated Moderna-Merck melanoma vaccine data surfaced before its planned ESMO presentation, disrupting the con...
A former lab director explains why Theranos clashed with routine medical care, while a reader reflects on the documentar...